Researcher.Life Logo

Journal of clinical and experimental hematopathology : JCEH : Impact Factor & More

eISSN: 1880-9952pISSN: 1346-4280
JournalOpen Access

Key Metrics

CiteScore
2.2
Recommended pre-submission checks
Powered by Paperpal by Editage

Journal of clinical and experimental hematopathology : JCEH Journal Specifications

Overview
Publisher JAPANESE SOC LYMPHORETICULAR TISSUE RESEARCH
Language English
Frequency Quarterly
Article Processing ChargesJPY 120000 | USD 1200
Publication Time11
Editorial Review ProcessPeer review
General Details
LanguageEnglish
Society/Institute/SponsorThe Japanese Society for Lymphoreticular Tissue Research
FrequencyQuarterly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-SA
OA statementVisit website
View less

Planning to publish in Journal of clinical and experimental hematopathology : JCEH ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of clinical and experimental hematopathology : JCEH

Suggestive characteristic change of CD123+dendritic cells in Kikuchi-Fujimoto Disease.
  • 28 Apr 2026
  • Journal of clinical and experimental hematopathology : JCEH
Fine-needle aspiration cytology of Hodgkin-like ALK-negative anaplastic large cell lymphoma: Cytomorphological clues and the diagnostic value of subtle background cell atypia.
  • 31 Mar 2026
  • Journal of clinical and experimental hematopathology : JCEH
Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH
Clinicopathological features of primary cold agglutinin disease in the Japanese population: Heterogeneous characteristics and diagnostic challenges.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH
Pseudoprogression of bladder extramedullary disease of multiple myeloma following the treatment with elranatamab, an anti-BCMA/CD3 bispecific antibody.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH
Adult T-cell leukaemia/lymphoma with different histological features in a single lymph node.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH
Suggestive characteristic change of CD123+dendritic cells in Kikuchi-Fujimoto Disease.
  • 28 Apr 2026
  • Journal of clinical and experimental hematopathology : JCEH
Fine-needle aspiration cytology of Hodgkin-like ALK-negative anaplastic large cell lymphoma: Cytomorphological clues and the diagnostic value of subtle background cell atypia.
  • 31 Mar 2026
  • Journal of clinical and experimental hematopathology : JCEH
Pseudoprogression of extramedullary lesions during elranatamab therapy in relapsed or refractory multiple myeloma.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH
Clinicopathological features of primary cold agglutinin disease in the Japanese population: Heterogeneous characteristics and diagnostic challenges.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH
Pseudoprogression of bladder extramedullary disease of multiple myeloma following the treatment with elranatamab, an anti-BCMA/CD3 bispecific antibody.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH
Adult T-cell leukaemia/lymphoma with different histological features in a single lymph node.
  • 1 Jan 2026
  • Journal of clinical and experimental hematopathology : JCEH

FAQs on Journal of clinical and experimental hematopathology : JCEH